Brief: Castle Biosciences Reports First Quarter 2023 Results

Castle Biosciences

03/05/2023 21:54

May 3 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * CASTLE BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTS
    * REAFFIRMING FULL-YEAR 2023 REVENUE IS EXPECTED TO BE
BETWEEN
$170-180 MILLION
    * Q1 2023 REVENUE INCREASED 57% OVER Q1 2022 TO $42 MILLION
    * AS OF MARCH 31, 2023, COMPANY'S CASH, CASH EQUIVALENTS AND
MARKETABLE INVESTMENT SECURITIES TOTALED $232.1 MILLION
    * QTRLY LOSS PER SHARE, BASIC AND DILUTED $1.10
    * Q1 EARNINGS PER SHARE VIEW $-0.89 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwbjLttYa 
Further company coverage:  CSTL.O 

 ((Reuters.Briefs@thomsonreuters.com;))